NCT02145442View on ClinicalTrials.gov

Effects of Obex in Overweight and Obese Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

November 30, 2014

Conditions
OverweightObesity
Interventions
DIETARY_SUPPLEMENT

Obex

Obex® will be administered two sachets daily dissolved in a glass of water, 30 minutes before lunch and dinner during three months. Participants will be not trained about changes of lifestyle on their diets, or physical activity.

Trial Locations (1)

10400

National Institute of Endocrinology, Plaza de la Revolución

All Listed Sponsors
lead

Catalysis SL

INDUSTRY

NCT02145442 - Effects of Obex in Overweight and Obese Patients | Biotech Hunter | Biotech Hunter